You are viewing an incomplete version of our website. Please click to reload the website as full version.

Human Cytokine Antibody Array C5

Details for Product No. ABIN625560, Supplier: Log in to see
Reactivity
Human
Methode Type
Sandwich ELISA
Application
Antibody Array (AA)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Purpose RayBio® Human Cytokine Antibody Array 5 (2 membrane arrays) with Accessories, for simultaneous detection of 80 Cytokines in 2 samples. Suitable for all sample types
Brand RayBio®
Sample Type Serum, Plasma, Cell Culture Supernatant, Cell Lysate, Tissue Lysate
ProductDetails: Analytical Method Semi-quantitative
Specificity Detects: Angiogenin,BDNF,BLC,CK beta 8-1,EGF,ENA-78, GCSF, GM-CSF, GRO, GRO-alpha, I-309, IL-1alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 p40p70, IL-13, IL-15, IFN-gamma, MCP-1, MCP-2, MCP-3, MCSF, MDC, MIG, MIP-1beta, MIP-1delta, RANTES, SCF, SDF-1, TARC, TGF-b1,TGF beta 2,TGF beta 3,Thrombopoietin(TPO),TIMP-1,TIMP-2,TNF alpha,TNF beta(TNFSF1B),VEGF-A
Components RayBio® Antibody Array Membranes
- Blocking Buffer
- Wash Buffer 1
- Wash Buffer 2
- Biotinylated Detection Antibody Cocktail
- Streptavidin-Conjugated HRP
- Detection Buffer C
- Detection Buffer D
- Lysis Buffer
- 8-Well Incubation Tray
- Plastic Sheets
- Array Templates
- Manual
Material not included Pipettors, pipet tips and other common lab consumables
Orbital shaker or oscillating rocker
Tissue Paper, blotting paper or chromatography paper
Adhesive tape or Saran Wrap
Distilled or de-ionized water
A chemiluminescent blot documentation system (such as UVP's ChemiDoc-It® or EpiChem II Benchtop Darkroom), X-ray Film and a suitable film processor, or another chemiluminescent detection system.
Background Cytokines play an important role in innate immunity, apoptosis, angiogenesis, cell growth and differentiation. They are involved in interactions between different cell types, cellular responses to environmental conditions, and maintenance of homeostasis. In addition, cytokines are also involved in most disease processes, including cancer and cardiac diseases.
Application Notes Perform ALL incubation and wash steps under gentle rotation or rocking motion (~0.5 to 1 cycle/sec) using an orbital shaker or oscillating rocker to ensure complete and even reagent/sample coverage. Rocking/rotating too vigorously may cause foaming or bubbles to appear on the membrane surface which, should be avoided. All washes and incubations should be performed in the Incubation Tray (ITEM 10) provided in the kit. Cover the Incubation Tray with the lid provided during all incubation steps to avoid evaporation and outside debris contamination. Ensure the membranes are completely covered with sufficient sample or reagent volume during each incubation. Avoid forceful pipetting directly onto the membrane; instead, gently pipette samples and reagents into a corner of each well. Aspirate samples and reagents completely after each step by suctioning off excess liquid with a pipette. Tilting the tray so the liquid moves to a corner and then pipetting is an effective method. Optional overnight incubations may be performed for the following step to increase overall spot signal intensities:
- Sample Incubation
- Biotinylated Antibody Cocktail Incubation
- HRP-Streptavidin Incubation
Comment

The C-Series arrays feature chemiluminescent signal detection. The antibodies are spotted on nitrocellulose membrane solid supports and are handled in a very similar manner to Western blots.

Sample Volume 1 mL
Plate Membrane
Protocol - Block membranes
- Incubate with Sample
- Incubate with Biotinylated Detection Antibody Cocktail
- Incubate with HRP-Conjugated Streptavidin
- Incubate with Detection Buffers
- Image with chemiluminescent imaging system
- Perform densitometry and analysis
Sample Preparation

Use serum-free conditioned media if possible. If serum-containing conditioned media is required, it is highly recommended that complete medium be used as a control since many types of sera contains cytokines. We recommend the following parameters for your samples: 50 to 100 µl of original or diluted serum, plasma, cell culture media, or other body fluid, or 50-500 µg/ml of protein for cell and tissue lysates. If you experience high background or if the fluorescent signal intensities exceed the detection range, further dilution of your sample is recommended.

Assay Procedure
  1. Place each membrane into the provided eight-well tray (- means the antibody printed side). 2. Add 2 ml 1X Blocking Buffer and incubate at room temperature for 30 min to block membranes. Note: incubation may be done at 4 °C for overnight. 3. Incubate membranes with 1ml of sample at room temperature for 1 to 2 hours. Dilute sample using 1X Blocking Buffer if necessary. Note: We recommend using 1 ml of Conditioned media or 1 ml of original or 10-fold diluted sera or plasma or 50-500 µg of protein for cell lysates and tissue lysates. Dilute the lysate at least 10 folds with 1 X blocking buffer. Note: The amount of sample used depends on the abundance of cytokines. More of the sample can be used if the signals are too weak. If the signals are too strong, the sample can be diluted further. Note: Incubation may be done at 4 °C for overnight. 4. Decant the samples from each container, and wash 3 times with 2 ml of 1X Wash Buffer I at room temperature with shaking. Please allow 5 min per wash. Dilute 20X Wash Buffer I with H 2 O. 5. Wash 2 times with 2 ml of 1X Wash Buffer II at room temperature with shaking. Allow 5 min per wash. Dilute 20X Wash Buffer II with H 2 O. 6. Prepare working solution for primary antibody. Add 100µl of 1X blocking buffer to the Biotin-Conjugated Anti- Cytokines tube. Mix gently and transfer all mixture to a tube containing 2 ml of 1X blocking buffer. Note: the diluted biotin-conjugated antibodies can be stored at 4 °C for 2-3 days. 7. Add 1 ml of diluted biotin-conjugated antibodies to each membrane. Incubate at room temperature for 1-2 hours. Note: incubation may be done at 4 °C for overnight. 8. Wash as directed in steps 4 and 5. 9. Add 2 ml of 1,000 fold diluted HRP-conjugated streptavidin (e.g. add 2 µl of HRP-conjugated streptavidin to 1998 µl 1X Blocking Buffer) to each membrane. Note: Mix the tube containing 1,000X HRP-Conjugated Streptavidin well before use since precipitation may form during storage. 10. Incubate at room temperature for 2 hours. Note: incubation may be done at 4 °C for overnight. 11. Wash as directed in steps 4 and 5.
    Do not let the membrane dry out during detection. The detection process must be completed within 40 minutes without stopping. 1. Proceed with the detection reaction. Add 250µl of 1X Detection Buffer C and 250µl of 1X Detection Buffer D for one membrane, mix both solutions. Drain off excess wash buffer by holding the membrane vertically with forceps. Place membrane protein side up ( - mark is on the protein side top left corner) on a clean plastic sheet (provided in the kit). Pipette the mixed Detection Buffer onto the membrane and incubate at room temperature for 2 minutes. Ensure that the detection mixture is completely and evenly covering the membrane without any air bubbles. 2. Drain off any excess detection reagent by holding the membrane vertically with forceps and touching the edge against a tissue. Gently place the membrane, protein side up, on a piece of plastic sheet ( - mark is on the protein side top left corner). Cover with another piece of plastic sheet on the array. Gently smooth out any air bubbles. Avoid using pressure on the membrane. 3. Expose the array to x-ray film (we recommend to use Kodak x-omat AR film) and detect signal using film developer. Or the signal can be detected directly from the membrane using a chemiluminescence imaging system. Expose the membranes for 40 seconds and then re-expose the film according to the intensity of signals. If the signals are too strong (background too high), reduce exposure time (e.g. 5-30 seconds). If the signals are too weak, increase exposure time (e.g. 5-20 min or overnight). Or re-incubate membranes overnight with 1x HRP-conjugated streptavidin, and redo detection in the second day. 4. Save membranes in -20° C to -80° C for future reference.
Calculation of Results

Visual comparison of array images may be sufficient to see differences in relative protein expression. However, most researchers will want to perform numerical comparisons of the signal intensities (or more precisely, signal densities), using 2-D densitometry. Gel/Blot documentation systems and other chemiluminescent or phosphorescent detection systems are usually sold as a package with compatible densitometry software. Any densitometry software should be sufficient to obtain spot signal densities from your scanned images. One such software program, ImageJ, is available for free from the NIH website along with an array plug-in.

Assay Precision Inter-array Coefficient of Variation (CV) of spot signal intensities as low as 5% when run under optimal conditions.
Restrictions For Research Use only
Handling Advice The antibody printed side of each membrane is marked by a dash (-) or number (#) in the upper left corner. Do not allow membranes to dry out during the experiment or they may become fragile and break OR high and/or uneven background may occur. Grasp membranes by the corners or edges only using forceps. DO NOT touch printed antibody spots.
Storage -20 °C
Storage Comment For best results, store the entire kit frozen at -20°C upon arrival. Stored frozen, the kit will be stable for at least 6 months which is the duration of the product warranty period. Once thawed, store array membranes and 1X Blocking Buffer at -20°C and all other reagents undiluted at 4°C for no more than 3 months.
Expiry Date 6 months
Product cited in: Li, Liao, Chiu et al.: "Effects of adrenomedullin on the expression of inflammatory cytokines and chemokines in oviducts from women with tubal ectopic pregnancy: an in-vitro experimental study." in: Reproductive biology and endocrinology : RB&E, Vol. 13, pp. 120, 2015 (PubMed).

Hao, Bai, Wang et al.: "Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera." in: BMC immunology, Vol. 16, pp. 25, 2015 (PubMed).

Duluc, Moatassim-Billah, Chalabi-Dchar et al.: "Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance." in: EMBO molecular medicine, Vol. 7, Issue 6, pp. 735-53, 2015 (PubMed).

Yeh, Shun, Kuo et al.: "Activated human valvular interstitial cells sustain interleukin-17 production to recruit neutrophils in infective endocarditis." in: Infection and immunity, Vol. 83, Issue 6, pp. 2202-12, 2015 (PubMed).

Sharif, Schmidt, Yi et al.: "Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling." in: Oncogene, 2015 (PubMed).

Kim, Jin, Sohn et al.: "Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling." in: Cancer letters, Vol. 353, Issue 2, pp. 194-200, 2014 (PubMed).

Sun, Mao, Wang et al.: "IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer." in: Oncogene, 2014 (PubMed).

Clarke, Imhoff, Baird: "Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase-1 and -2." in: Molecular carcinogenesis, 2014 (PubMed).

Stieler, Schumacher, Horst et al.: "XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?" in: PLoS ONE, Vol. 7, Issue 7, pp. e42321, 2012 (PubMed).

Korkaya, Kim, Davis et al.: "Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population." in: Molecular cell, Vol. 47, Issue 4, pp. 570-84, 2012 (PubMed).

Kim, Oskarsson, Acharyya et al.: "Tumor self-seeding by circulating cancer cells." in: Cell, Vol. 139, Issue 7, pp. 1315-26, 2010 (PubMed).

Reverter, Nadal, Fernández-Novell et al.: "Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy." in: Investigative ophthalmology & visual science, Vol. 50, Issue 3, pp. 1378-82, 2009 (PubMed).

Acosta, OLoghlen, Banito et al.: "Chemokine signaling via the CXCR2 receptor reinforces senescence." in: Cell, Vol. 133, Issue 6, pp. 1006-18, 2008 (PubMed).

McAllister, Gifford, Greiner et al.: "Systemic endocrine instigation of indolent tumor growth requires osteopontin." in: Cell, Vol. 133, Issue 6, pp. 994-1005, 2008 (PubMed).

Hon, Ching, Wong et al.: "A pilot study to explore the usefulness of antibody array in childhood atopic dermatitis." in: Journal of the National Medical Association, Vol. 100, Issue 5, pp. 500-4, 2008 (PubMed).

Wendt, Wilk, Buyny et al.: "Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells." in: Journal of leukocyte biology, Vol. 80, Issue 6, pp. 1529-41, 2006 (PubMed).

Hashimoto, Wada, Hida et al.: "Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects." in: Obesity (Silver Spring, Md.), Vol. 14, Issue 5, pp. 799-811, 2006 (PubMed).

Swiderski: "[Studies on the histogenesis of locomotor system damages due to constant overload. I. Muscles and bones]." in: Beiträge zur Orthopädie und Traumatologie, Vol. 13, Issue 4, pp. 218-23 (PubMed).

Novik: "[Abduction fractures of the femoral neck and their complications]." in: Vestnik khirurgii imeni I. I. Grekova, Vol. 94, Issue 1, pp. 50-5 (PubMed).

Blanda: "[Rupture of varicose veins of the round ligament in pregnancy, simulating a strangulated hernia]." in: Minerva ginecologica, Vol. 21, Issue 2, pp. 48-50 (PubMed).

Mann, Revach, Call et al.: "Prevalence and distribution of caries in a Jerusalem adolescent population by age, sex, and family income." in: Journal of public health dentistry, Vol. 49, Issue 3, pp. 158-62, 1989 (PubMed).